We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters to the Editor |

Homeopathic vs Conventional Treatment of Vertigo—Reply

Michael Weiser, MBChB; Wolfgang Strösser, MD, MBChB; Peter Klein, MSc
Arch Otolaryngol Head Neck Surg. 2003;129(4):498. doi:10.1001/archotol.129.4.497-a.
Text Size: A A A
Published online


In reply

We thank Prof Sampson for his comments. As he mentioned in his letter, for a long time no product was approved for peripheral vertigo by the FDA. The fact that there were no appropriate treatments for Meniere disease and that vertiginous patients benefited from a nonspecific or placebo effect of therapy was yet concluded by Torok1 in 1977. In the meantime the current knowledge of the pathogenesis and treatment of vertigo and especially of Meniere disease gained increasing data quality. Twenty years later Claes and van de Heyning2 discussed the vestibular sedative, antiemetic, vasoactive, and diuretic effects of a couple of substances that are used in the treatment of Meniere disease in their review of literature. Betahistine is described as significantly more effective than placebo in 2 of 3 double-blind, randomized clinical trials, with a more favorable effect than a diuretic or piperazine comparator.2,3


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...